Biopharmaceutical & Biotechnology Companies is the fastest growing segment, North America is the largest market globally
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
Advancements in regenerative medicine and cell and gene therapies represent a crucial impetus for the global cell expansion market. Progress in understanding and manipulating cellular processes has led to novel therapeutic modalities inherently reliant on efficient and scalable cell proliferation. Significant regulatory milestones underscore this trend. According to Forbes, in January 2024, the FDA approved Casgevy, a CRISPR gene-editing treatment, for transfusion-dependent beta thalassemia, following its approval for sickle cell disease in December 2023.Key Market Challenges
The high cost associated with advanced cell expansion technologies and the manufacturing processes for cell-based products poses a significant barrier to the global cell expansion market's growth. These substantial financial outlays directly affect research and development budgets, creating hurdles for smaller organizations and new entrants to develop or scale their operations. The considerable capital expenditure required for specialized equipment and facilities, coupled with the ongoing operational expenses for maintaining sterile environments and expert personnel, results in elevated production costs for cell-based therapies.Key Market Trends
Advancements in automated and digitalized cell expansion systems are fundamentally reshaping the cell expansion landscape by introducing unparalleled efficiency, consistency, and scalability. These systems minimize human intervention, reducing contamination risk and process variability inherent in manual operations. Digitalization enhances these benefits through real-time monitoring and data analytics, which are critical for maintaining stringent quality standards in large-scale cell production. According to the World Health Organization, global biopharmaceutical production capacity increased by 35% between 2020 and 2023, necessitating optimized manufacturing processes.Key Market Players Profiled:
- Thermo Fisher Scientific, Inc.
- Corning Incorporated
- Merck KGaA
- Miltenyi Biotec B.V. & Co. KG
- Becton, Dickinson and Company (BD)
- Terumo BCT, Inc.
- Sartorius AG
- Takara Bio USA, Inc.
- TRINOVA BIOCHEM GmbH
- Upcyte Technologies GmbH
Report Scope:
In this report, the Global Cell Expansion Market has been segmented into the following categories:By Product:
- Consumables
- Culture Flasks and Accessories
- Instruments
By Cell Type:
- Mammalian
- Human
- Microbial
- Others
By Application:
- Biopharmaceuticals
- Tissue Culture & Engineering
- Vaccine Production
- Drug Development
- Gene Therapy
- Cancer Research
- Stem Cell Research
- Others
By End-use:
- Biopharmaceutical & Biotechnology Companies
- Research Institutes
- Cell Banks
- Others
By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cell Expansion Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Corning Incorporated
- Merck KGaA
- Miltenyi Biotec B.V. & Co. KG
- Becton, Dickinson and Company (BD)
- Terumo BCT, Inc.
- Sartorius AG
- Takara Bio USA, Inc.
- TRINOVA BIOCHEM GmbH
- Upcyte Technologies GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | November 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 16.78 Billion |
| Forecasted Market Value ( USD | $ 30.51 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |


